首页>
外国专利>
pyrroloquinoline quinine lithium salt crystal, method of preparation of pyrroloquinoline quinine lithium salt crystal and pharmaceutical composition
pyrroloquinoline quinine lithium salt crystal, method of preparation of pyrroloquinoline quinine lithium salt crystal and pharmaceutical composition
展开▼
机译:吡咯并喹啉奎宁锂盐晶体,吡咯并喹啉奎宁锂盐晶体的制备方法和药物组合物
展开▼
页面导航
摘要
著录项
相似文献
摘要
Summary Pyrroloquinoline Quinine Lithium Salt Crystal, Method of Preparation of Pyrroloquinoline Quinine Lithium Salt Crystal and Pharmaceutical Composition The present invention provides the pyrroloquinoline quinone lithium salt crystal and a method of preparing and applying it. characteristic absorption peaks appear when the diffraction angles are 6,222 ± 0,2 °, 7,379 ± 0,2 °, 7,941 ± 0,2 °, 23,631 ± 0,2 °, 24,044 ± 0,2 °, 25,497 ± 0, 2 °, 27.541 ± 0.2 °, 30.736 ± 0.2 °, and 32.306 ± 0.2 ° degrees in an x-ray powder diffraction pattern of pyrroloquinoline quinine lithium salt. Does the maximum thermal absorption value of the pyrroloquinoline quinine lithium salt crystal appear between 90? and 96? through differential scanning calorimetry. peaks appear when the infrared spectroscopy of the pyrroloquinoline quinine lithium salt crystal is at 3396.03 cm -1, 1652.70 cm -1, 1604.48 cm -1, 1500.35 cm -1, 1355.71 cm -1, 1243.86 cm -1, 1147.44 cm -1, 808.03 cm -1, 761.74 cm -1, and 570.83 cm -1. The pyrroloquinoline quinine lithium salt polymorphism can be applied to the preparation of drugs for the cure of memory impairment. 1/1
展开▼
机译:发明内容吡咯并喹啉奎宁锂盐晶体,制备方法和药物组合物本发明提供了吡咯并喹啉奎宁锂盐晶体及其制备和应用方法。当衍射角为6,222±0.2°,7,379±0.2°,7941±0.2°,23,631±0.2°,24,044±0.2°,25,497±0、2°时出现特征吸收峰吡咯并喹啉奎宁锂盐的X射线粉末衍射图谱中分别为27.541±0.2°,30.736±0.2°和32.306±0.2°。吡咯并喹啉奎宁锂盐晶体的最大热吸收值是否在90之间?和96?通过差示扫描量热法。当吡咯并喹啉奎宁锂盐晶体的红外光谱在3396.03 cm -1,1652.70 cm -1,1604.48 cm -1,1500.35 cm -1,1355.71 cm -1,1243.86 cm -1,1147.44 cm -1,出现峰808.03 cm -1、761.74 cm -1和570.83 cm -1。吡咯并喹啉奎宁锂盐多态性可用于制备治疗记忆障碍的药物。 1/1
展开▼